| Vaccine Therapy in Preventing Cancer Recurrence in Patients With Non-Metastatic, Node Positive, HER2 Negative Breast Cancer That is in Remission |
Laboratory Biomarker Analysis, pUMVC3-IGFBP2-HER2-IGF1R Plasmid DNA Vaccine, Sargramostim |
Active, not recruiting |
| Curcumin in Preventing Gastric Cancer in Patients With Chronic Atrophic Gastritis or Gastric Intestinal Metaplasia |
Curcumin, Laboratory Biomarker Analysis, Quality-of-Life Assessment, Placebo Administration |
Active, not recruiting |
| Understanding and Predicting Breast Cancer Events After Treatment |
Cardiac MRI |
Active, not recruiting |
| Chemoprevention of Gastric Carcinogenesis |
Eflornithine, Eflornithine placebo |
Active, not recruiting |
| Identifying, Understanding, and Overcoming Barriers to the Use of Clinical Practice Guidelines in Pediatric Oncology |
Informational Intervention, Interview, Medical Chart Review, Questionnaire Administration |
Active, not recruiting |
| Retinoid 9cUAB30 in Producing a Biologic Effect in Patients With Early Stage Breast Cancer |
Retinoid 9cUAB30, Therapeutic Conventional Surgery, Biospecimen Collection |
Active, not recruiting |
| Abbreviated Breast MRI and Digital Tomosynthesis Mammography in Screening Women With Dense Breasts |
Contrast-enhanced Magnetic Resonance Imaging, Digital Tomosynthesis Mammography, Quality-of-Life Assessment, Questionnaire Administration |
Active, not recruiting |
| Aspirin in Preventing Colorectal Cancer in Patients With Colorectal Adenoma |
Aspirin, Questionnaire Administration, Placebo Administration, Biospecimen Collection, Rectal Biopsy |
Active, not recruiting |
| Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis |
Questionnaire Administration, Simvastatin, Placebo Administration |
Active, not recruiting |
| Testing an Active Form of Tamoxifen (4-hydroxytamoxifen) Delivered Through the Breast Skin to Control Ductal Carcinoma in Situ (DCIS) of the Breast |
Afimoxifene, Laboratory Biomarker Analysis, Placebo, Tamoxifen Citrate |
Recruiting |